Mosa Meat, located in Maastricht, The Netherlands, has received $55 million in funding from investment groups including Blue Horizon Ventures. Mosa Meat previously produced a single, but very expensive small patty. During the past two years, the company has apparently reduced costs through technical innovations. Mosa Meats claims to have removed fetal bovine serum from growth media, considered critical to acceptance by vegans. Funding will be used to extend production from current laboratory scale to a pilot plant although no dates have been provided for completion of the project.
Maarten Bosch, CEO of Mosa Meat, stated, “We are very excited to welcome our new partners and see existing partners continue our journey together.” He added, “With their support and capabilities we have the opportunity to take the next concrete steps to scale production.” Dr. Regina Hecker, partner at Blue Horizon Ventures who will join the board stated, “Following a thorough investigation of its technology and team, we are convinced that Mosa Meats is strongly placed to pioneer the scale-up of cultured meat.”